**Core Concept**
Metformin is a commonly used oral antidiabetic medication that requires careful consideration in patients with liver and renal failure due to its potential for lactic acidosis, a serious and potentially life-threatening condition.

**Why the Correct Answer is Right**
The correct answer is Metformin, as it is generally safe in both liver and renal failure. This is because Metformin does not require renal excretion and its metabolism is not significantly affected by liver function. Furthermore, Metformin's mechanism of action involves decreasing hepatic glucose production and increasing insulin sensitivity, making it an effective antidiabetic agent even in patients with compromised liver and renal function.

**Why Each Wrong Option is Incorrect**
* **Option A:** Sulfonylureas - These drugs are contraindicated in liver and renal failure as they can cause hypoglycemia and are excreted by the kidneys.
* **Option B:** Pioglitazone - This medication is contraindicated in liver failure due to the risk of hepatotoxicity and is also not recommended in renal failure due to its potential for fluid retention.
* **Option C:** Repaglinide - This drug is contraindicated in liver and renal failure as it can cause hypoglycemia and is excreted by the kidneys.

**Clinical Pearl / High-Yield Fact**
When managing patients with diabetes and liver or renal failure, it's essential to consider the potential for drug interactions and to choose antidiabetic medications that are safe and effective in these patients.

**Correct Answer:** A. Metformin